Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion.

Cytokines Exhaustion Immune dysregulation Lymphocytes SARS-CoV-2

Journal

Seminars in immunology
ISSN: 1096-3618
Titre abrégé: Semin Immunol
Pays: England
ID NLM: 9009458

Informations de publication

Date de publication:
06 2021
Historique:
received: 30 07 2021
revised: 11 10 2021
accepted: 15 10 2021
pubmed: 4 11 2021
medline: 21 12 2021
entrez: 3 11 2021
Statut: ppublish

Résumé

One and half year following the occurrence of COVID-19 pandemic, significant efforts from laboratories all over the world generated a huge amount of data describing the prototypical features of immunity in the course of SARS-CoV-2 infection. In this Review, we rationalize and organize the main observations, trying to define a "core" signature of immunity in COVID-19. We identified six hallmarks describing the main alterations occurring in the early infection phase and in the course of the disease, which predispose to severe illness. The six hallmarks are dysregulated type I IFN activity, hyperinflammation, lymphopenia, lymphocyte impairment, dysregulated myeloid response, and heterogeneous adaptive immunity to SARS-CoV-2. Dysregulation and exhaustion came out as the trait d'union, connecting abnormalities affecting both innate and adaptive immunity, humoral and cellular responses.

Identifiants

pubmed: 34728121
pii: S1044-5323(21)00039-7
doi: 10.1016/j.smim.2021.101508
pmc: PMC8547971
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101508

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Auteurs

Alessio Mazzoni (A)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Lorenzo Salvati (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Laura Maggi (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Francesco Annunziato (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: francesco.annunziato@unifi.it.

Lorenzo Cosmi (L)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH